- Home
- LIQT vs GOVX Comparison
LIQT vs GOVX Comparison
Compare LIQT & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIQT
- GOVX
- Stock Information
- Founded
- LIQT 2004
- GOVX 2001
- Country
- LIQT Denmark
- GOVX United States
- Employees
- LIQT N/A
- GOVX N/A
- Industry
- LIQT Industrial Machinery/Components
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- LIQT Technology
- GOVX Health Care
- Exchange
- LIQT Nasdaq
- GOVX Nasdaq
- Market Cap
- LIQT 16.1M
- GOVX 16.8M
- IPO Year
- LIQT N/A
- GOVX N/A
- Fundamental
- Price
- LIQT $2.45
- GOVX $0.56
- Analyst Decision
- LIQT Strong Buy
- GOVX Strong Buy
- Analyst Count
- LIQT 1
- GOVX 3
- Target Price
- LIQT $3.60
- GOVX $10.67
- AVG Volume (30 Days)
- LIQT 20.2K
- GOVX 1.3M
- Earning Date
- LIQT 11-13-2025
- GOVX 11-11-2025
- Dividend Yield
- LIQT N/A
- GOVX N/A
- EPS Growth
- LIQT N/A
- GOVX N/A
- EPS
- LIQT N/A
- GOVX N/A
- Revenue
- LIQT $15,459,242.00
- GOVX $6,143,044.00
- Revenue This Year
- LIQT $36.89
- GOVX N/A
- Revenue Next Year
- LIQT $16.33
- GOVX N/A
- P/E Ratio
- LIQT N/A
- GOVX N/A
- Revenue Growth
- LIQT N/A
- GOVX 1943.07
- 52 Week Low
- LIQT $1.34
- GOVX $0.43
- 52 Week High
- LIQT $3.35
- GOVX $3.88
- Technical
- Relative Strength Index (RSI)
- LIQT 47.58
- GOVX 46.77
- Support Level
- LIQT $2.31
- GOVX $0.52
- Resistance Level
- LIQT $2.65
- GOVX $0.61
- Average True Range (ATR)
- LIQT 0.27
- GOVX 0.04
- MACD
- LIQT -0.05
- GOVX 0.00
- Stochastic Oscillator
- LIQT 23.09
- GOVX 48.00
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.